Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil legislates to raise hanseniasis detection:

This article was originally published in Clinica

Executive Summary

The Brazilian health ministry has approved a decree setting out a strategy aimed at eliminating hanseniasis. The government is seeking to increase detection by 30% in the more than 607 municipalities worst affected by the disease, with the aim of reducing its incidence to less than one per 10,000 inhabitants by 2005. It has allocated R$48m (US$12.1m) in 2002 to jointly tackle hanseniasis and tuberculosis. The decree, approved on October 9 2002, sets out a system of incentives by which municipalities and state authorities will receive R$60 and R$10, respectively, for every new confirmed case.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068538

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel